au.\*:("MOURI, Akihiro")
Results 1 to 12 of 12
Selection :
Phencyclidine animal models of schizophrenia : Approaches from abnormality of glutamatergic neurotransmission and neurodevelopmentMOURI, Akihiro; NODA, Yukihiro; ENOMOTO, Takeshi et al.Neurochemistry international. 2007, Vol 51, Num 2-4, pp 173-184, issn 0197-0186, 12 p.Article
Mucosal immunotherapy in an Alzheimer mouse model by recombinant Sendai virus vector carrying Aβ1-43/IL-10 cDNAHARA, Hideo; MOURI, Akihiro; YONEMITSU, Yoshikazu et al.Vaccine. 2011, Vol 29, Num 43, pp 7474-7482, issn 0264-410X, 9 p.Article
Novel rare variants in F-box protein 45 (FBX045) in schizophreniaCHENYAO WANG; KOIDE, Takayoshi; JINGRUI XING et al.Schizophrenia research. 2014, Vol 157, Num 1-3, pp 149-156, issn 0920-9964, 8 p.Article
The allosteric potentiation of nicotinic acetylcholine receptors by galantamine ameliorates the cognitive dysfunction in beta amyloid25-35 I.c.v.-injected mice : Involvement of dopaminergic systemsDAYONG WANG; NODA, Yukihiro; YUAN ZHOU et al.Neuropsychopharmacology (New York, NY). 2007, Vol 32, Num 6, pp 1261-1271, issn 0893-133X, 11 p.Article
Thyrotoropin receptor knockout changes monoaminergic neuronal system and produces methylphenidate-sensitive emotional and cognitive dysfunctionMOURI, Akihiro; HOSHINO, Yuta; NARUSAWA, Shiho et al.Psychoneuroendocrinology. 2014, Vol 48, pp 147-161, issn 0306-4530, 15 p.Article
Role of matrix metalloproteinase and tissue inhibitor of MMP in methamphetamine-induced behavioral sensitization and reward : implications for dopamine receptor down-regulation and dopamine releaseMIZOGUCHI, Hiroyuki; YAMADA, Kiyofumi; MOURI, Akihiro et al.Journal of neurochemistry. 2007, Vol 102, Num 5, pp 1548-1560, issn 0022-3042, 13 p.Article
Identification of Novel Candidate Genes for Treatment Response to Risperidone and Susceptibility for Schizophrenia: Integrated Analysis Among Pharmacogenomics, Mouse Expression, and Genetic Case-Control Association ApproachesIKEDA, Masashi; TOMITA, Yasuyuki; TAKEDA, Masatoshi et al.Biological psychiatry (1969). 2010, Vol 67, Num 3, pp 263-269, issn 0006-3223, 7 p.Article
Silibinin attenuates cognitive deficits and decreases of dopamine and serotonin induced by repeated methamphetamine treatmentPING LU; MAMIYA, Takayoshi; NABESHIMA, Toshitaka et al.Behavioural brain research. 2010, Vol 207, Num 2, pp 387-393, issn 0166-4328, 7 p.Article
Inhibition of neprilysin by thiorphan (i.c.v.) causes an accumulation of amyloid β and impairment of learning and memoryMOURI, Akihiro; ZOU, Li-Bo; IWATA, Nobuhisa et al.Behavioural brain research. 2006, Vol 168, Num 1, pp 83-91, issn 0166-4328, 9 p.Article
Combination of neonatal PolyI:C and adolescent phencyclidine treatments is required to induce behavioral abnormalities with overexpression of GLAST in adult miceHIDA, Hirotake; MOURI, Akihiro; YU ANDO et al.Behavioural brain research. 2014, Vol 258, pp 34-42, issn 0166-4328, 9 p.Article
Xanthoceraside attenuates amyloid β peptide25―35-induced learning and memory impairments in micePING LU; MAMIYA, Takayoshi; LINGLING LU et al.Psychopharmacologia. 2012, Vol 219, Num 1, pp 181-190, issn 0033-3158, 10 p.Article
Prenatal exposure to PCP produces behavioral deficits accompanied by the overexpression of GLAST in the prefrontal cortex of postpubertal miceLINGLING LU; MAMIYA, Takayoshi; PING LU et al.Behavioural brain research. 2011, Vol 220, Num 1, pp 132-139, issn 0166-4328, 8 p.Article